Blood News and Research

RSS

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

A third COVID-19 vaccine dose in this patients with blood cancers could enhance their antibody responses against SARS-CoV-2

21 Nov 2022

UC San Diego receives $8 million CIRM funding to expedite stem cell therapy clinical trials

Stem cells show particular promise in treating diseases for which few other effective treatments exist. In these therapies, stem cells are introduced into the body where they develop into specialized cells that repair, restore, replace or regenerate cells that have been damaged by the disease.

21 Nov 2022

Study challenges "good" cholesterol's predictive role for heart disease

A National Institutes of Health-supported study found that high-density lipoprotein (HDL) cholesterol, often called the "good cholesterol," may not be as effective as scientists once believed in uniformly predicting cardiovascular disease risk among adults of different racial and ethnic backgrounds.

21 Nov 2022

Cost-saving Medicare Advantage may be a disadvantage for complex cancer surgery patients

An analysis by researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, found that cancer patients with privatized, cost-saving Medicare Advantage were more likely than those with traditional Medicare to go to hospitals with physicians less experienced at performing complicated surgeries, and that they were more likely to die within the first 30 days after the removal of their stomach, pancreas or liver.

21 Nov 2022

Comprehensive analysis outlines the potential toxicities of antibody drug conjugates

Over the past two decades, numerous complex cancer therapies called antibody drug conjugates (ADCs) have been tested in clinical trials and approved for use in patients.

21 Nov 2022

Researchers identify best methods to study resting state of the brain in marmosets

A team led by researchers from Tokyo Metropolitan University have identified the best methods to study the resting state of the brain in marmosets using functional MRI.

21 Nov 2022

Evaluating cell-free DNA-based blood tests for early detection of multiple cancers

Researchers assessed several approaches for a circulating cell-free deoxyribonucleic acid (cfDNA)-based multi-cancer early detection (MCED) test. Defining the clinical limit of detection (LOD) based on circulating tumor allele fraction (cTAF) enables the comparison of different approaches.

21 Nov 2022

Increase in Candida auris infections among EU/EEA nations between 2020 and 2021

Researchers evaluated the trends in Candida auris infections among European Union/European Economic Area (EU/EUA) nations between 2020 and 2021.

21 Nov 2022

Hungary sees 116% growth in non-invasive prenatal testing

...

From BGI Genomics 21 Nov 2022

MRI reveals brain changes in patients up to six months after COVID-19 recovery

Using a special type of MRI, researchers have uncovered brain changes in patients up to six months after they recovered from COVID-19, according to a study being presented next week at the annual meeting of the Radiological Society of North America.

21 Nov 2022

SARS-CoV-2 infection and mRNA vaccination prime transcriptionally distinct CD4+ T cell memory landscapes

Researchers reported that SARS-CoV-2 infection and mRNA vaccination induce distinct memory T cells.

21 Nov 2022

Enormous rise in Acinetobacter bloodstream infection cases in initial two years of COVID-19

In a new study, researchers investigated Acinetobacter species bloodstream infection (BSI) case counts from a subset of laboratory data continuously reported during the initial two years of SARS-CoV-2 infections, i.e., from 2020 to 2021.

21 Nov 2022

Better access to quality diabetes education needed for a healthier future

Today, the International Sweeteners Association (ISA) is delighted to renew its support to World Diabetes Day (WDD) for the eleventh consecutive year, joining the call to action from the International Diabetes Federation (IDF) to highlight the need for better access to quality diabetes education to protect tomorrow.

21 Nov 2022

UCF researcher examines the mechanisms of COVID-19 pathogenesis in patients with diabetes

Can a COVID-19 infection have long-term health effects on people with diabetes, including advancing their risk for heart disease?

20 Nov 2022

Rutgers scientists develop new approach to effectively shut down viral infections

Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for vaccine development.

20 Nov 2022

In our rapidly changing world, parasites and vectors thrive

Recently, researchers reviewed the incidence and management of emerging parasites and vectors associated with human and veterinary organisms.

20 Nov 2022

Unusual Zika virus-specific antibody exhibits ultrapotent neutralization

An unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection undetectable in preclinical models has been identified by a team led by Weill Cornell Medicine, NewYork-Presbyterian and National Institutes of Health (NIH) investigators.

20 Nov 2022

Caregivers’ coping strategies affect their level of distress and quality of life

November is Caregiver Awareness Month, and timely findings from a study published in Blood Advances suggest that, among caregivers of patients undergoing a stem cell transplant, how someone approaches coping can influence their levels of anxiety, depression, and poor quality of life (QOL) they experience.

20 Nov 2022

First-of-its-kind brain surgery simulator appears to be a feasible approach for training neurosurgeons

Hundreds of residents in neurological surgery across the United States trained on a first-of-its-kind simulator intended to mimic the type of real-life catastrophe they may face in operating rooms.

20 Nov 2022

FDA approves first-ever type 1 diabetes delaying drug Tzield (teplizumab-mzwv)

On November 17, 2022, the US Food and Drug Administration (FDA) approved a pathbreaking new drug called Tzield. This injectable formulation contains a combination of two drugs that could push back the onset of type 1 diabetes (T1D) in adults at stage 3 and children aged eight years or more at stage 2.

20 Nov 2022

Blood News and Research

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

UC San Diego receives $8 million CIRM funding to expedite stem cell therapy clinical trials

Study challenges "good" cholesterol's predictive role for heart disease

Cost-saving Medicare Advantage may be a disadvantage for complex cancer surgery patients

Comprehensive analysis outlines the potential toxicities of antibody drug conjugates

Researchers identify best methods to study resting state of the brain in marmosets

Evaluating cell-free DNA-based blood tests for early detection of multiple cancers

Increase in Candida auris infections among EU/EEA nations between 2020 and 2021

Hungary sees 116% growth in non-invasive prenatal testing

MRI reveals brain changes in patients up to six months after COVID-19 recovery

SARS-CoV-2 infection and mRNA vaccination prime transcriptionally distinct CD4+ T cell memory landscapes

Enormous rise in Acinetobacter bloodstream infection cases in initial two years of COVID-19

Better access to quality diabetes education needed for a healthier future

UCF researcher examines the mechanisms of COVID-19 pathogenesis in patients with diabetes

Rutgers scientists develop new approach to effectively shut down viral infections

In our rapidly changing world, parasites and vectors thrive

Unusual Zika virus-specific antibody exhibits ultrapotent neutralization

Caregivers’ coping strategies affect their level of distress and quality of life

First-of-its-kind brain surgery simulator appears to be a feasible approach for training neurosurgeons

FDA approves first-ever type 1 diabetes delaying drug Tzield (teplizumab-mzwv)

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News